Latest Articles
Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report - EurekAlert!
Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report EurekAlert!
Published: Aug. 4, 2026, 7:14 p.m.
Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report - eurekalert.org
Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report eurekalert.org
Published: Aug. 4, 2026, 7:14 p.m.
Endometrial Carcinosarcoma in a Young Female with Absence of Established Risk Factors: A Case Report - Frontiers
Endometrial Carcinosarcoma in a Young Female with Absence of Established Risk Factors: A Case Report Frontiers
Published: Sept. 15, 2025, 5:41 p.m.
ROCSAN Study Step I Misses 16-Week ORR End Point in Endometrial or Ovarian Carcinosarcoma - OncLive
ROCSAN Study Step I Misses 16-Week ORR End Point in Endometrial or Ovarian Carcinosarcoma OncLive
Published: June 20, 2024, 7 a.m.
Link copied to clipboard!